UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
AMC cardiologist Kang publishes 2nd paper in esteemed US journal
Kang Duk-hyun, a professor of the Department of Cardiology at Asan Medical ...
by Lee Han-soo
|
2019-11-18 18:09
라인
Korea, ASEAN to expand cooperation in pharmaceutical sector
Korea will strengthen cooperation with the member countries of the Associat...
by Lee Han-soo
|
2019-11-18 16:52
라인
Doctor fuels controversy with YouTube advice on how to take dog dewormer
Recently, several cancer patients were admitted to university hospitals due...
by Lee Hye-seon
|
2019-11-18 16:47
라인
SNUBH identifies differences of schizophrenia according to causes
Seoul National University Bundang Hospital (SNUBH) said it has identified t...
by Lee Han-soo
|
2019-11-18 16:31
라인
‘Udenafil improved exercise in single ventricle heart disease’
Mezzion Pharma said its investigational drug udenafil improved exercise cap...
by Jeong Sae-im
|
2019-11-18 14:48
라인
SNUH develops method to reduce prostate cancer surgery’s side effects
Researchers at Seoul National University Hospital (SNUH) have developed a n...
by Lee Han-soo
|
2019-11-18 14:33
라인
Korea good at cancer treatment, bad at outpatient drug control
Korea has steadily improved the quality of acute treatment and care for out...
by Kwak Sung-sun
|
2019-11-18 14:02
라인
Seegene to supply antibiotic resistance test kit to Italy
Seegene said that it has won a bid to supply Allplex Entero-DR, an intestin...
by Lee Han-soo
|
2019-11-18 13:57
라인
“Xalkori-Alecensa sequential therapy advantageous in duration of treatment”
Given the licensing and insurance system in Korea, the Xalkori-Alecensa seq...
by Kim Yun-mi
|
2019-11-15 17:48
라인
Ministry revokes Kolon Life Science’s innovative drug company status
The Ministry of Health and Welfare revoked Kolon Life Science’s innovative ...
by Lee Han-soo
|
2019-11-15 17:26
라인
Regulator presents guideline for smart contact lens measuring blood sugar
The Ministry of Food and Drug Safety said that it has set up a new guidelin...
by Lee Han-soo
|
2019-11-15 15:22
라인
Seegene posts ₩31.4 billion in Q3 sales
Seegene recorded sales of 31.4 billion won ($26.9 million) in the third qua...
by Lee Han-soo
|
2019-11-15 13:50
라인
AbbVie presents new data for ankylosing spondylitis treatment in US
AbbVie has presented positive data from its phase 2 and 3 SELECT-AXIS 1 tri...
by Lee Han-soo
|
2019-11-15 11:40
라인
JW Medical sells Hitachi's ultrasound scanner device
JW Medical, a subsidiary of JW Holdings, said that it has begun to market A...
by Lee Han-soo
|
2019-11-15 11:39
라인
Merck Korea wins award for helping families with infertility problems
Merck Biopharma Korea said that it received the National Assembly's Hea...
by Lee Han-soo
|
2019-11-14 18:05
라인
Huons to sell Insightec's MRI-guided ultrasound system in Korea
Huons said that it would market the Israeli medical device company Insighte...
by Lee Han-soo
|
2019-11-14 17:06
라인
'DTC genetic testing service providers should improve quality of information'
The direct-to-consumer (DTC) genetic testing market has grown exponentially...
by Lee Han-soo
|
2019-11-14 15:27
라인
Prosecutors raid drugmakers, distributors for suspected bid-rigging
Prosecutors have begun investigating local drug companies and distributors ...
by Jeong Sae-im
|
2019-11-14 15:27
라인
71.5% of doctors experience verbal, physical attack from patients
Seven out of 10 physicians said they have been attacked verbally or physica...
by Choi Gwang-seok
|
2019-11-14 15:25
라인
‘Novartis’ Kymriah takes one step closer to cancer cure’
Novartis has recently drawn the attention of local industry watchers concer...
by Lee Han-soo
|
2019-11-14 13:24
-
이전
81
82
83
84
85
86
87
88
89
90
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top